GENSCRIPT Trademark

Trademark Overview

On Monday, July 21, 2014, a trademark application was filed for GENSCRIPT with the United States Patent and Trademark Office. The USPTO has given the GENSCRIPT trademark a serial number of 86342662. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, December 24, 2025. This trademark is owned by GenScript USA Incorporated. The GENSCRIPT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific, technological and medical research services, namely, the service of providing gene synthesis, oligo synthesis, cloning, protein expression, peptide synthesis and antibody production, genome modification, cell line establishment, animal model establishment, in vivo and in vitro assays

General Information

Serial Number86342662
Word MarkGENSCRIPT
Filing DateMonday, July 21, 2014
Status800 - REGISTERED AND RENEWED
Status DateWednesday, December 24, 2025
Registration Number4833056
Registration DateTuesday, October 13, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 16, 2014

Trademark Statements

Pseudo MarkGEN SCRIPT
Goods and ServicesScientific, technological and medical research services, namely, the service of providing gene synthesis, oligo synthesis, cloning, protein expression, peptide synthesis and antibody production, genome modification, cell line establishment, animal model establishment, in vivo and in vitro assays

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 25, 2014
Primary Code042
First Use Anywhere DateSaturday, October 19, 2002
First Use In Commerce DateSaturday, October 19, 2002

Trademark Owner History

Party NameNANJING GENSCRIPT BIOTECH CO., LTD.
Party Type32 - New Owner After Registration
Legal Entity Type99 - Other
AddressJIANGSU 211100
CN
Party NameNANJINGJINSIRUI SCIENCE & TECHNOLOGY BIOLOGY CORP.
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressNanjing, Jiangsu 211100
CN
Party NameGenScript USA Incorporated
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPiscataway, NJ 08854
Party NameGenScript USA Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPiscataway, NJ 08854
Party NameGenScript USA Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPiscataway, NJ 08854

Trademark Events

Event DateEvent Description
Thursday, July 24, 2014NEW APPLICATION ENTERED
Friday, July 25, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 26, 2014NOTICE OF PSEUDO MARK E-MAILED
Monday, November 3, 2014ASSIGNED TO EXAMINER
Monday, November 10, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 26, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 16, 2014PUBLISHED FOR OPPOSITION
Tuesday, December 16, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, December 17, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 17, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 10, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 24, 2015TEAS STATEMENT OF USE RECEIVED
Tuesday, August 11, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 24, 2015USE AMENDMENT FILED
Saturday, August 15, 2015STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 10, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 11, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 13, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, February 19, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, April 2, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 2, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 2, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 2, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, April 2, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 2, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 2, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, October 13, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 13, 2020TEAS SECTION 8 & 15 RECEIVED
Wednesday, October 14, 2020TEAS SECTION 8 & 15 RECEIVED
Wednesday, December 16, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, January 25, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, February 1, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, February 1, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, October 13, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, September 17, 2025TEAS SECTION 8 & 9 RECEIVED
Wednesday, December 24, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, December 24, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, December 24, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, December 24, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

genscript synthesis establishment modification assays genome production antibody cell line vivo